NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vector Group Ltd.
(NYSE:VGR), NovoCure Limited (NASDAQ:NVCR), ORBCOMM Inc. (NASDAQ:ORBC), Ecolab Inc. (NYSE:ECL), Bank of America Corporation
(NYSE:BAC), and Viking Therapeutics, Inc. (NASDAQ:VKTX), including updated fundamental summaries, consolidated fiscal reporting,
and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
VGR DOWNLOAD: http://Fundamental-Markets.com/register/?so=VGR
NVCR DOWNLOAD: http://Fundamental-Markets.com/register/?so=NVCR
ORBC DOWNLOAD: http://Fundamental-Markets.com/register/?so=ORBC
ECL DOWNLOAD: http://Fundamental-Markets.com/register/?so=ECL
BAC DOWNLOAD: http://Fundamental-Markets.com/register/?so=BAC
VKTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=VKTX
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Vector Group Ltd. (NYSE:VGR), NovoCure Limited (NASDAQ:NVCR), ORBCOMM Inc. (NASDAQ:ORBC), Ecolab Inc. (NYSE:ECL), Bank of America
Corporation (NYSE:BAC), and Viking Therapeutics, Inc. (NASDAQ:VKTX) on a fundamental level and outlines the overall demand for
their products and services in addition to an in-depth review of the business strategy, management discussion, and overall
direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. All information in this release was accessed
November 19th, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material
information. All amounts in millions (except per share amounts).
-----------------------------------------
VECTOR GROUP LTD. (VGR) REPORT OVERVIEW
Vector Group's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Vector Group reported revenue of
$484.63 vs $459.10 (up 5.56%) and diluted earnings per share $0.13 vs $0.17 (down 23.53%). For the twelve months ended December
31st, 2016 vs December 31st, 2015, Vector Group reported revenue of $1,690.95 vs $1,657.20 (up 2.04%) and diluted earnings per
share $0.52 vs $0.44 (up 19.56%). Vector Group is expected to report earnings on March 7th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.12. The estimated EPS forecast for the
next fiscal year is $0.66 and is expected to report on March 7th, 2018.
To read the full Vector Group Ltd. (VGR) report, download it here: http://Fundamental-Markets.com/register/?so=VGR
-----------------------------------------
NOVOCURE LIMITED (NVCR) REPORT OVERVIEW
NovoCure's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, NovoCure reported revenue of $50.11 vs
$21.67 (up 131.19%) and diluted earnings per share -$0.13 vs -$0.39. For the twelve months ended December 31st, 2016 vs December
31st, 2015, NovoCure reported revenue of $82.89 vs $33.09 (up 150.52%) and diluted earnings per share -$1.54 vs -$3.67. NovoCure is
expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The
reported EPS for the same quarter last year was -$0.26. The estimated EPS forecast for the next fiscal year is -$0.36 and is
expected to report on February 22nd, 2018.
To read the full NovoCure Limited (NVCR) report, download it here: http://Fundamental-Markets.com/register/?so=NVCR
-----------------------------------------
ORBCOMM INC. (ORBC) REPORT OVERVIEW
ORBCOMM's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, ORBCOMM reported revenue of $69.37 vs
$46.29 (up 49.86%) and diluted earnings per share -$0.54 vs -$0.20. For the twelve months ended December 31st, 2016 vs December
31st, 2015, ORBCOMM reported revenue of $186.74 vs $178.29 (up 4.74%) and diluted earnings per share -$0.33 vs -$0.19. ORBCOMM is
expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The
reported EPS for the same quarter last year was -$0.04. The estimated EPS forecast for the next fiscal year is -$0.15 and is
expected to report on February 27th, 2018.
To read the full ORBCOMM Inc. (ORBC) report, download it here: http://Fundamental-Markets.com/register/?so=ORBC
-----------------------------------------
ECOLAB INC. (ECL) REPORT OVERVIEW
Ecolab's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Ecolab reported revenue of $3,563.30 vs
$3,386.10 (up 5.23%) and diluted earnings per share $1.34 vs $1.27 (up 5.51%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Ecolab reported revenue of $13,152.80 vs $13,545.10 (down 2.90%) and diluted earnings per share $4.14 vs $3.32
(up 24.70%). Ecolab is expected to report earnings on February 20th, 2018. The report will be for the fiscal period ending December
31st, 2017. The reported EPS for the same quarter last year was $1.25. The estimated EPS forecast for the next fiscal year is $5.33
and is expected to report on February 20th, 2018.
To read the full Ecolab Inc. (ECL) report, download it here: http://Fundamental-Markets.com/register/?so=ECL
-----------------------------------------
BANK OF AMERICA CORPORATION (BAC) REPORT OVERVIEW
Bank of America's Recent Financial Performance
Bank of America is expected to report earnings on January 12th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next
fiscal year is $2.13 and is expected to report on January 12th, 2018.
To read the full Bank of America Corporation (BAC) report, download it here: http://Fundamental-Markets.com/register/?so=BAC
-----------------------------------------
VIKING THERAPEUTICS, INC. (VKTX) REPORT OVERVIEW
Viking Therapeutics' Recent Financial Performance
Viking Therapeutics is expected to report earnings on March 20th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next
fiscal year is -$0.72 and is expected to report on March 20th, 2018.
To read the full Viking Therapeutics, Inc. (VKTX) report, download it here: http://Fundamental-Markets.com/register/?so=VKTX
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
